Matthew J. Frigault, MD, provides expert insights on multidisciplinary management of CRS and neurotoxicity associated with CAR T-cell therapies.
Listen to Shaji Kumar, MD discuss the latest clinical data and treatment recommendations for managing your patients with myeloma.
Interactive online tool providing expert and guideline-based recommendations for assessing and managing CAR T-cell therapy toxicities, from CCO
Expert insights on treatment strategies for patients with relapsed/refractory multiple myeloma
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.